135 related articles for article (PubMed ID: 12369964)
1. FKBP ligands as novel therapeutics for neurological disorders.
Christner C; Herdegen T; Fischer G
Mini Rev Med Chem; 2001 Nov; 1(4):377-97. PubMed ID: 12369964
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders.
Gold BG
Expert Opin Investig Drugs; 2000 Oct; 9(10):2331-42. PubMed ID: 11060810
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
4. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain.
Brecht S; Schwarze K; Waetzig V; Christner C; Heiland S; Fischer G; Sartor K; Herdegen T
Neuroscience; 2003; 120(4):1037-48. PubMed ID: 12927209
[TBL] [Abstract][Full Text] [Related]
5. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
6. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
Monaghan P; Bell A
Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.
Perrucci GL; Gowran A; Zanobini M; Capogrossi MC; Pompilio G; Nigro P
Cardiovasc Res; 2015 Jun; 106(3):353-64. PubMed ID: 25750190
[TBL] [Abstract][Full Text] [Related]
8. FK506 and the role of immunophilins in nerve regeneration.
Gold BG
Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
[TBL] [Abstract][Full Text] [Related]
9. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
11. Neuroimmunophilin ligands: the development of novel neuroregenerative/ neuroprotective compounds.
Gold BG; Villafranca JE
Curr Top Med Chem; 2003; 3(12):1368-75. PubMed ID: 12871168
[TBL] [Abstract][Full Text] [Related]
12. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands.
Yu L; Fesik SW
Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680
[TBL] [Abstract][Full Text] [Related]
13. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
15. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.
Gerard M; Deleersnijder A; Demeulemeester J; Debyser Z; Baekelandt V
Mol Neurobiol; 2011 Aug; 44(1):13-27. PubMed ID: 21553017
[TBL] [Abstract][Full Text] [Related]
17. Diverse structures, functions and uses of FK506 binding proteins.
Bonner JM; Boulianne GL
Cell Signal; 2017 Oct; 38():97-105. PubMed ID: 28652145
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
Zarnt T; Lang K; Burtscher H; Fischer G
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity.
Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D
Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036
[TBL] [Abstract][Full Text] [Related]
20. FK506-binding protein-type peptidyl-prolyl cis-trans isomerase from a halophilic archaeum, Halobacterium cutirubrum.
Iida T; Iwabuchi T; Ideno A; Suzuki S; Maruyama T
Gene; 2000 Oct; 256(1-2):319-26. PubMed ID: 11054562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
